Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection
Top Cited Papers
Open Access
- 5 March 2021
- Vol. 13 (3), 422
- https://doi.org/10.3390/v13030422
Abstract
Although antibody levels progressively decrease following SARS-CoV-2 infection, the immune memory persists for months. Thus, individuals who naturally contracted SARS-CoV-2 are expected to develop a more rapid and sustained response to COVID-19 vaccines than naïve individuals. In this study, we analyzed the dynamics of the antibody response to the BNT162b2 mRNA COVID-19 vaccine in six healthcare workers who contracted SARS-CoV-2 in March 2020, in comparison to nine control subjects without a previous infection. The vaccine was well tolerated by both groups, with no significant difference in the frequency of vaccine-associated side effects, with the exception of local pain, which was more common in previously infected subjects. Overall, the titers of neutralizing antibodies were markedly higher in response to the vaccine than after natural infection. In all subjects with pre-existing immunity, a rapid increase in anti-spike receptor-binding domain (RBD) IgG antibodies and neutralizing antibody titers was observed one week after the first dose, which seemed to act as a booster. Notably, in previously infected individuals, neutralizing antibody titers 7 days after the first vaccine dose were not significantly different from those observed in naïve subjects 7 days after the second vaccine dose. These results suggest that, in previously infected people, a single dose of the vaccine might be sufficient to induce an effective response.Keywords
Funding Information
- Horizon 2020 (874735)
- I.R.C.C.S. Sacro Cuore Don Calabria Hospital (Fondi Ricerca Corrente – L1P6)
This publication has 18 references indexed in Scilit:
- Antibody responses boosted in seropositive healthcare workers after single dose of SARS-CoV-2 mRNA vaccinePublished by Cold Spring Harbor Laboratory ,2021
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infectionScience, 2021
- A cautionary note on recall vaccination in ex-COVID-19 subjectsPublished by Cold Spring Harbor Laboratory ,2021
- Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccinePublished by Cold Spring Harbor Laboratory ,2021
- Single Dose Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2Published by Cold Spring Harbor Laboratory ,2021
- Protection of Healthcare Workers Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) ReinfectionClinical Infectious Diseases, 2021
- Evolution of antibody immunity to SARS-CoV-2Nature, 2021
- Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020Published by Cold Spring Harbor Laboratory ,2021
- Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients SemiquantitativelyJournal of Clinical Microbiology, 2020
- Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)Emerging Microbes & Infections, 2020